On this episode of the dvm360 Vet Blast podcast, Dr. Derek Matthews, board-certified veterinary cardiologist at Thrive Pet Healthcare Specialists North Scottsdale in Arizona, talks with dvm360's Dr. Adam Christman about feline cardiology and sirolimus delayed-release tablets (felycin-CA1). They discuss the medicine, who it should and should not be prescribed to, what to look out for, and previous research, including the results of the RAPACAT trial, which were published in the Journal of the American Veterinary Medical Association.
About Derek Matthews, DVM, DACVIM (Cardiology)
Matthews is a board-certified veterinary cardiologist at
Thrive Pet Healthcare Specialists in North Scottsdale, Arizona. He earned his Doctor of Veterinary Medicine degree from Colorado State University in 2015. He went on to complete a rotating internship in small animal medicine and surgery at Purdue University, followed by a cardiology residency at Texas A&M University. In 2019, he became a diplomate of the American College of Veterinary Internal Medicine in Cardiology. His clinical interests include arrhythmias, congenital heart disease, interventional procedures, and the management of congestive heart failure. He is also leading a clinical study on a new treatment for cats with cardiomyopathy.
